Trial site
Solaris Clinical Research
- 19running trials
- 12closed trials
The trials here
What the 31 trials at this site are about, from their registry records.
- Conditions
- Obesity20 trials
- Type 2 diabetes17 trials
- Type 1 diabetes2 trials
- Atopic dermatitis (eczema)1 trial
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- High blood pressure1 trial
- Phase
- Phase 327 trials
- Phase 23 trials
- Phase 41 trial
- Status
- Active, not recruiting12 trials
- Completed11 trials
- Recruiting6 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Novo Nordisk A/S12 trials
- Eli Lilly and Company8 trials
- Amgen5 trials
- Boehringer Ingelheim3 trials
- Novartis Pharmaceuticals2 trials
- and 1 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity5 recruiting
- Type 2 diabetes3 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026